Vall d'Hebron Hospital

Treatment & access

• Treatments offeredEsketamine nasal spray (Spravato®)
• Access routeTrial
• Cost & coverage (registry status)Free within clinical trial
• Websitehttps://www.vallhebron.com

About this provider

Compiled from the registry data on this page.

Vall d'Hebron Hospital (Passeig de la Vall d'Hebron 119-129) in Barcelona, Spain, is listed as a clinical trial site for esketamine (Spravato). The entry is based on CTIS, the EU Clinical Trials Information System, trial 2024-512672-34-00: the CESAR study comparing esketamine nasal spray with aripiprazole, both combined with an antidepressant, in refractory major depression (RMDD) in elderly patients, sponsored by Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla. Access is through trial participation, and treatment is free within the clinical trial. The CTIS public record is the registry source cited by this entry. The record was last verified on 2026-07-29.

4 more verified providers within 50 km

• L'Hospitalet de Llobregat (Barcelona) · 7 kmHospital Universitari de Bellvitge — Unidad de Depresión Resistente : Spravato®
• Sant Boi De Llobregat · 12 kmFundació Hospitalàries Sant Boi : Clinical trials
• Sabadell, Barcelona · 19 kmCorporacion Sanitaria Parc Tauli : Clinical trials

See them on the provider map →

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.